Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Editor information Editors and Affiliations Rights and permissions Copyright information 2017 Springer International Publishing AG About this entry Cite this entry Stoopler, E.T., Alawi, F
Despite their origins in diabetes management, GLP-1 agonists are now widely used for weight loss in non-diabetic individuals and have been approved for this purpose by the FDA
Anti-Ageing Support: May help enhance skin glow and fight early signs of ageing, such as dull and wrinkled skin
Sitagliptin (Aschner et al., 2006), saxagliptin (Rosenstock et al., 2009), and vildagliptin (Keating, 2010) all improve glucose metabolism in diabetic patients
Complete a short online health questionnaire in under 5 minutes
Based on these researches, clinical trials targeting HO-1 should be carried out to evaluate its application in the treatment of DN, so as to provide evidence for clinical application
